Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/News/Breakthrough! Eli Lilly’s Weight Loss Drug Triumphs in Reducing Diabetes Risk – Discover the Hope for a Healthier Future
News

Breakthrough! Eli Lilly’s Weight Loss Drug Triumphs in Reducing Diabetes Risk – Discover the Hope for a Healthier Future

By adminitfy
August 20, 2024 2 Min Read

Eli Lilly’s groundbreaking weight loss drug, tirzepatide, has demonstrated remarkable efficacy in reducing the risk of Type 2 diabetes by 94% in obese or overweight adults with prediabetes, according to preliminary results from a long-term study published Tuesday. The study, which spanned nearly three years, revealed that participants on the highest weekly dose of tirzepatide experienced an average weight loss of 22.9%, compared to just 2.1% for those on a placebo.

Tirzepatide, the active ingredient in Eli Lilly’s Zepbound and Mounjaro, could significantly delay the onset of diabetes in individuals with prediabetes—those with elevated blood sugar levels not yet severe enough to be classified as Type 2 diabetes. With more than a third of Americans experiencing prediabetes—a condition often reversible through diet and exercise—these findings underscore the drug’s potential long-term health benefits.

The phase three trial, involving over 1,000 adults and lasting 176 weeks with a follow-up period of 17 weeks post-treatment, is the most extensive study on tirzepatide to date. While those who discontinued the drug saw a resurgence in weight and progression towards diabetes, they still had an 88% lower risk of developing the disease compared to placebo recipients.

Tirzepatide works by mimicking gut hormones GLP-1 and GIP, which help suppress appetite and regulate blood sugar. The drug’s safety profile remained consistent with earlier studies, with mild to moderate gastrointestinal side effects being the most common.

Eli Lilly plans to present these findings at a medical conference in November and will submit them to a peer-reviewed journal. Dr. Jeff Emmick, Eli Lilly’s senior VP of product development, emphasized that these results reinforce the clinical benefits of long-term therapy for individuals with obesity and prediabetes.

As the popularity of GLP-1-based medications like Zepbound and Mounjaro continues to rise, this study highlights their wide-ranging potential beyond weight loss, inspiring further clinical research.

Original Story https://www.cnbc.com/2024/08/20/eli-lilly-weight-loss-drug-cuts-risk-of-developing-diabetes-in-trial.html
Category :
Tags:

Author

adminitfy

Follow Me
Other Articles
Previous

Indian Firms Set to Fuel Economic Boom with $50 Billion Annual Investments Amidst Surging Profits

Next

Victory for Activism: FIR Against Shrinkhal Chaliha Withdrawn Amidst ULFA(I) Intervention

Search...

Recent Posts

  • India’s 200M AC Surge by 2035 to Lift Electricity Demand 6%: IEA
    India’s 200M AC Surge by 2035 to Lift Electricity Demand 6%: IEA
    by adminitfy
    November 22, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • India’s 200M AC Surge by 2035 to Lift Electricity Demand 6%: IEA
  • Tura Civil Hospital Achieves Rare Diaphragmatic Hernia Surgery First
  • The AAA Ownership Gap: Why India Builds Worlds It Doesn’t Own
  • Dhubri Bar Election: Record 91% Turnout, Ahmed Elected President
  • Assam Fake Certificate Crackdown: 75+ Nagaon Schools File FIRs
  • November 2026 (688)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.